top of page
1775229634606_edited.jpg

MESSAGE FROM FOUNDER

Cannula_edited.png
Cannula_edited_edited.jpg
IM3_edited.jpg

Dear Colleague,

​

As a board-certified general surgeon with over 40 years of clinical experience and CEO of MagStone Ventures Inc., I am excited to personally invite you to explore a rare and high-potential investment opportunity of minimally invasive surgery, cosmetic procedures, and cutting-edge AI technology.

Our company is pioneering the next generation of micro-cannula systems — intelligent tools designed to elevate both precision and safety in aesthetic and therapeutic procedures. At the core of our innovation is a Smart Cannula Systems®  that enables surgeons to:

  • Visualize the entire treatment area in real time

  • Record high-fidelity 3D procedural data

  • Apply AI-driven analytics to optimize technique on-the-fly

  • Seamlessly transition from manual to robotic-assisted delivery

This breakthrough system addresses key challenges in the rapidly growing cosmetic and minimally invasive surgery market: inconsistent outcomes, limited intra-operative visibility and the need for greater control and reproducibility. Backed by multiple pending patents, our technology positions MagStone Ventures at the forefront of a transformation that promises improved patient safety, better aesthetic results. We are still in early stage of research and development. We are building partnerships with medical institutions and healthcare providers and biomedical engineers for prototyping, testing and refining systems efficacy and regulatory compliance. We are continuously improving the system and we are working hard  to bring out the surgical tool which will change the industry.

Smart Cannula Systems: Intelligence Meets Precision in Body Contouring

Imagine a liposuction cannula that doesn’t just remove fat — it thinks alongside the surgeon.

Smart Cannula Systems fuse AI-powered sensors, real-time tissue analysis, motion tracking, into a single intelligent platform. It eliminates blind passes optimizing fat extraction, preventing over or under-treatment and dynamically guiding skin-tightening energy delivery — all while slashing procedure time and surgeon fatigue.

Why invest now? The perfect storm is hitting the aesthetic surgery market.

  • The global liposuction devices market is exploding, valued at ~USD 2.2B in 2025 and projected to reach $5.2B by 2033 at an 11.9% CAGR.

  • Surging demand for high-precision body sculpting is fueled by rising obesity awareness, aesthetic consciousness — and critically, the massive wave of rapid weight loss from semaglutide (Ozempic/Wegovy) and other GLP-1 drugs. These medications are creating millions of patients with excess skin and stubborn fat pockets who now seek refined contouring and skin tightening.

  • Today’s tools remain “dumb” metal tubes. Smart cannulas deliver the same leap that robotics brought to orthopedics and general surgery: from manual guesswork to AI-assisted, data-driven precision.

Our clear competitive edge:

  • Significantly lower complication rates: reduced bruising, swelling, and contour irregularities

  • Superior, highly reproducible outcomes with minimal operator variability

  • Faster patient recovery → higher surgeon and clinic throughput → stronger margins

  • Scalable, future-proof platform ready for robotic integration, cloud-based analytics, and personalized AI treatment planning

We’re not selling another cannula. We’re selling the operating room of tomorrow — where every pass is optimized, every result is predictable, every procedure is safer, faster, and more profitable.

Invest in Smart Cannula Systems and capture the intelligent future of the multi-billion-dollar aesthetic surgery revolution.

The age of smart liposuction is here. Let’s build it — and dominate it — together.

 By investing at this early stage, you gain the chance to:

  • Participate in shaping the future of minimally invasive procedures

  • Secure a strategic position in a high-growth sector

  • Benefit from significant upside as we advance toward commercialization and clinical adoption

  This is an opportunity for visionary partners to join innovation and excellence. We are actively seeking investors in order to bring the Smart Cannula Systems from prototype stage to commercial use. Together, we can drive meaningful advancements that benefit both patients and forward-thinking medical professionals.

Warm regards,

Indrek Miidla, MD CEO & Founder MagStone Ventures Inc. Email: info@magstoneventures.com

mob 954-607-7177.

​

bottom of page